Follow
Timothy Welty
Timothy Welty
Professor of Pharmacy Practice, Drake University
Verified email at drake.edu
Title
Cited by
Cited by
Year
American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice
JE Murphy, JM Nappi, JA Bosso, JJ Saseen, BA Hemstreet, MA Halloran, ...
Pharmacotherapy 26 (5), 722-733, 2006
2752006
Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy
A Prasad, RI Kuzniecky, RC Knowlton, TE Welty, RC Martin, M Mendez, ...
Archives of neurology 60 (8), 1100-1105, 2003
1282003
Impact of vancomycin therapeutic drug monitoring on patient care
TE Welty, AK Copa
Annals of Pharmacotherapy 28 (12), 1335-1339, 1994
1221994
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial
MD Privitera, TE Welty, BE Gidal, FJ Diaz, R Krebill, JP Szaflarski, ...
The Lancet Neurology 15 (4), 365-372, 2016
1082016
Vagus nerve stimulation for partial seizures.
MD Privitera, TE Welty, DM Ficker, J Welge
The Cochrane Database of Systematic Reviews, CD002896-CD002896, 2002
104*2002
Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee
DG Vossler, JL Bainbridge, JG Boggs, EJ Novotny, T Loddenkemper, ...
Epilepsy Currents 20 (5), 245-264, 2020
812020
Cannabidiol: Promise and pitfalls: Cannabidiol: Promise and pitfalls
TE Welty, A Luebke, BE Gidal
Epilepsy currents 14 (5), 250-252, 2014
802014
Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies
M Yamada, TE Welty
Annals of Pharmacotherapy 45 (11), 1406-1415, 2011
752011
Management of hallucinations and psychosis in Parkinson's disease
ML Eng, TE Welty
The American journal of geriatric pharmacotherapy 8 (4), 316-330, 2010
752010
Point-of-care testing: an introduction
SL Gutierres, TE Welty
Annals of Pharmacotherapy 38 (1), 119-125, 2004
732004
Loss of seizure control associated with generic substitution of carbamazepine
TE Welty, PR Pickering, BC Hale, R Arazi
Annals of Pharmacotherapy 26 (6), 775-777, 1992
721992
A controlled study of progabide in partial seizures: methodology and results
IE Leppik, FE Dreifuss, R Porter, T Bowman, N Santilli, M Jacobs, ...
Neurology 37 (6), 963-963, 1987
601987
A double-blind crossover evaluation of progabide in partial seizures
IE Leppik, FE Dreifuss, T Bowman-Cloyd, N Santilli, M Jacobs, C Crosby, ...
Neurology 35 (4), 285, 1985
581985
The essential research curriculum for doctor of pharmacy degree programs
MW Lee, PG Clay, WK Kennedy, MJ Kennedy, NM Sifontis, D Simonson, ...
Pharmacotherapy 30 (9), 966, 2010
572010
Levetiracetam: a different approach to the pharmacotherapy of epilepsy
TE Welty, BE Gidal, DM Ficker, MD Privitera
Annals of Pharmacotherapy 36 (2), 296-304, 2002
542002
Bioequivalence between generic and branded lamotrigine in people with epilepsy: the EQUIGEN randomized clinical trial
M Berg, TE Welty, BE Gidal, FJ Diaz, R Krebill, JP Szaflarski, ...
Jama Neurology 74 (8), 919-926, 2017
522017
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force
JA French, E Perucca, JW Sander, L Bergfeldt, M Baulac, DS Auerbach, ...
Epilepsy currents 21 (3), 150-153, 2021
502021
Pathophysiology and treatment of subarachnoid hemorrhage.
TE Welty, TG Horner
Clinical pharmacy 9 (1), 35-39, 1990
481990
Effect of limited transportation on medication adherence in patients with epilepsy
TE Welty, SL Willis, EA Welty
Journal of the American Pharmacists Association 50 (6), 698-703, 2010
382010
Revisiting the significance of warfarin protein-binding displacement interactions
CD Sands, ES Chan, TE Welty
Annals of Pharmacotherapy 36 (10), 1642-1644, 2002
362002
The system can't perform the operation now. Try again later.
Articles 1–20